Checklist identification of candidates for systemic therapy in adult patients with atopic dermatitis in Germany: A multicentre study
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19465 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von A Heratizadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AbbVie Deutschland.
Abstract (Originalsprache)
Background
The German S2k guideline is the first to include a checklist that captures atopic dermatitis (AD) signs and symptoms as well as the lack of treatment response to identify patients eligible for systemic therapy.
Objectives
Identifying candidates for a start/switch of systemic therapy in adult AD patients in Germany by applying the S2k guideline's checklist.
Methods
In this German multicentre, cross‐sectional, non‐interventional study (German Clinical Trials Register number: DRKS00023296), adult patients with mild to severe AD were enrolled at dermatological outpatient clinics and offices between April and October 2021. Demographics, clinical characteristics and quality of life were collected using questionnaires during one single visit. Eligibility for a start/switch of systemic AD therapy was evaluated according to the criteria of the German S2k guideline's checklist.
Results
Atopic dermatitis patients (575) were included in the analysis. One hundred and sixty‐four patients (28.5%) received systemic (SYS) AD therapy and 411 patients (71.5%) did not (TOP). Of the TOP therapy patients, 38.7% were eligible to start systemic AD therapy, and about half of those (49.1%), were scheduled to start systemic AD therapy. The most frequent reason deciding against a systemic therapy was the patient's wish. Although 29.3% of SYS patients were eligible for a switch according to the criteria of the German S2k guideline's checklist, the majority (81.3%) did not switch AD therapy.
Conclusions
This is the first study on the implementation of the German S2k guideline's checklist in everyday care of AD patients in Germany. More than one‐third of the TOP patients were identified as eligible for systemic treatment. By applying the guideline's checklist criteria, another one‐third of SYS patients may have benefited from a change of current systemic therapy. The use of the German S2k guideline's checklist in routine care represents an important tool to ensure effective patient care and identify inadequately treated patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
- Hautarztpraxis Elmshorn, Elmshorn, Germany.
- Company for Medical Study & Service Selters GmbH (CMS), Selters, Germany.
- formerly AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
- AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
ORCID-Profile: A Heratizadeh
Förderung
- AbbVie Deutschland
Zitieren
APA
Heratizadeh, A., Mempel, M., von Kiedrowski, R., Hagl, S., Mosch, T., Fritz, B., & Werfel, T. (2024). Checklist identification of candidates for systemic therapy in adult patients with atopic dermatitis in Germany: A multicentre study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19465
Vancouver
Heratizadeh A, Mempel M, von Kiedrowski R, Hagl S, Mosch T, Fritz B, et al. Checklist identification of candidates for systemic therapy in adult patients with atopic dermatitis in Germany: A multicentre study. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19465
BibTeX
@article{Heratizadeh2024,
author = {Heratizadeh, A and Mempel, M and von Kiedrowski, R and Hagl, S and Mosch, T and Fritz, B and Werfel, T},
title = {Checklist identification of candidates for systemic therapy in adult patients with atopic dermatitis in Germany: A multicentre study},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19465}
}
EUVIMED